ASRT Assertio Holdings Inc.

Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020

Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020

LAKE FOREST, Ill., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief executive officer and director, Todd Smith will present at and participate in investor meetings at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020. The presentation will take place at 11:20 am ET

A live audio webcast of the presentation can be accessed through the Investors section of the Company's website at . A replay of the webcast will be available on the Company's website following the live presentation.

About Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions. The Company seeks to leverage its commercial excellence to be the partner of choice. To learn more about Assertio, visit .

Investor Contact

Lee Roth

Burns McClellan for Assertio Holdings, Inc.



 

EN
10/11/2020

Underlying

ASRTAssertio Holdings Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Assertio Holdings Inc.

 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports Second Quarter 2025 Financial Results

Assertio Reports Second Quarter 2025 Financial Results Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the second quarter ended June 30, 2025. Said Brendan O...

August 11, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Result...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans. To access the live webcast, conference call inform...

August 5, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio to Participate in the Alliance Global Partners Healthcare Com...

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at , or visit the Events & Presentations page at the Company’s investor relations websit...

May 19, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports First Quarter 2025 Financial Results

Assertio Reports First Quarter 2025 Financial Results First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the first quarter ende...

May 12, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and update the Company’s 2025 strategic plans. To access the live webcast, conference call information, and other materials, ...

May 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch